¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ )p MZ5|+X  
{.We%{4V  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£©  KUf k5Y  
T x_n$ &   
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© %$ ^yot  
"R$ee^  
1.Co-stimulators (or co-stimulating molecules) 877>=Tp |  
?o h3t  
2.NK-kB @|&P#wd.u  
DVYY1!j<  
3.Immunoglobulin superfamily <3;/,>^ Pm  
cI3uH1;#  
4.antigen-presenting cell (APC) %Gn(b 1X  
R Nr=M^Zn  
5.death domain l}X3uy S  
voaRh@DZ%/  
6.CCR and CXCR 17G7r\iNYq  
nTj Q4y  
7.Lectin (or mitogen) Dj>.)n  
AKM \1H3U  
8.Clusters of differentiation, CD) U %Aj~K^b  
6^['g-\2  
9.B7 family +D1;_D U  
MQ"<r,o?:  
10.Cytotoxic T lymphocyte, CTL) }6eWdm!B  
`c{ i +  
11.IL-15 and IL-15 receptor (IL-15R) lN1T\  
=#1iio&  
12.MHC restriction XLFJ?$)Tro  
%@*diJ  
13.Affinity-chromatography jKQnox+=  
l4u`R(!n5  
14.Cyctosprin A, CsA QsI>_<r  
E](Ood  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) ep[7#\}5  
Abce]-E  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© W 3 2mAz;  
Wuye: b!  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ^']xkS  
KWy4}7a@,s  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ tTF/$`Q#*  
!=cW+=1  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ )F]E[sga  
lpve Yz  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© :(A]Bm3  
u;~/B[  
ÃâÒßѧרҵ£º T -C2V$1  
v8 gg PI  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ InNuK0@  
'!{zO" 1*  
Ïû»¯ÄÚ¿Æ£º +Medu?K `  
x1$fkNu  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ N$>g)Ml?  
R(r89bTQ  
ѪҺ²¡Ñ§×¨Òµ£º f]%$HfF @  
fX#Em'Ab[  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
5+2=? ÕýÈ·´ð°¸:7
°´"Ctrl+Enter"Ö±½ÓÌá½»